Meta Biomed Co., Ltd. (KOSDAQ:059210)
3,935.00
+55.00 (1.42%)
At close: Jul 16, 2026
Meta Biomed Market Cap
Meta Biomed has a market cap or net worth of 106.92 billion as of July 17, 2026. Its market cap has decreased by -24.95% in one year.
Market Cap
106.92B
Enterprise Value
113.83B
Revenue
99.67B
Ranking
n/a
PE Ratio
10.98
Stock Price
3,935.00
ChartMarket Cap Chart
Since April 15, 2008, Meta Biomed's market cap has increased from 42.60B to 106.92B, an increase of 150.99%. That is a compound annual growth rate of 5.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 106.92B | -20.51% |
| Dec 30, 2025 | 134.50B | 58.52% |
| Dec 30, 2024 | 84.85B | -14.91% |
| Dec 28, 2023 | 99.72B | 88.74% |
| Dec 29, 2022 | 52.83B | -20.17% |
| Dec 30, 2021 | 66.18B | 2.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FNS TECH. | 107.40B |
| Gradiant | 107.34B |
| Chemtros | 107.28B |
| ESTec | 107.23B |
| Codes Combine | 107.02B |
| Genexine | 106.88B |
| Solborn | 106.87B |
| Woorison F&G | 106.76B |